Abstract
AbstractBeing able to predict the human oral bioavailability for a potential new drug is extremely important for the drug discovery process. This problem has been addressed by several prediction tools, with Genetic Programming providing some of the best results ever achieved. In this paper we use the newest state-of-the-art developments of Genetic Programming, in particular the latest bloat control method, to find out exactly how much improvement we can achieve on this problem.We show examples of some actual solutions and discuss their quality from the practitioners’ point of view, comparing them with previously published results. We identify some unexpected behaviors and discuss the way for further improving the practical usage of the Genetic Programming approach.KeywordsGenetic ProgrammingPractical UsageUnexpected BehaviorDrug Discovery ProcessTraining FitnessThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
